相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy
Scott Wilkinson et al.
EUROPEAN UROLOGY (2021)
Functional mapping of androgen receptor enhancer activity
Chia-Chi Flora Huang et al.
GENOME BIOLOGY (2021)
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer
Alexandra N. Corella et al.
CLINICAL CANCER RESEARCH (2020)
A case report of multiple primary prostate tumors with differential drug sensitivity
Scott Wilkinson et al.
NATURE COMMUNICATIONS (2020)
Mitochondrial localization, import, and mitochondrial function of the androgen receptor
Prachi Bajpai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
Wenjing Su et al.
CANCER CELL (2019)
The androgen receptor regulates a druggable translational regulon in advanced prostate cancer
Yuzhen Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Mark P. Labrecque et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
Srinivas R. Viswanathan et al.
CELL (2018)
Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27)
Jianzhuo Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
Qiuhui Li et al.
NATURE COMMUNICATIONS (2018)
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
Ping Mu et al.
SCIENCE (2017)
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Sheng Yu Ku et al.
SCIENCE (2017)
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn et al.
CANCER CELL (2017)
Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance
Manish Kohli et al.
CLINICAL CANCER RESEARCH (2017)
Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4
Adam G. Sowalsky et al.
CLINICAL CANCER RESEARCH (2017)
Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer
Xin Chen et al.
CLINICAL CANCER RESEARCH (2016)
Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein
Shuai Gao et al.
CELL REPORTS (2016)
Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications
Qu Deng et al.
ENDOCRINE-RELATED CANCER (2015)
Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells
Xin Liu et al.
ONCOTARGET (2015)
High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure
Thea Grindstad et al.
PLOS ONE (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
Jonathan I. Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
Hsueh-Li Tan et al.
CLINICAL CANCER RESEARCH (2014)
Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer
Kathryn E. Ware et al.
ENDOCRINE-RELATED CANCER (2014)
Conversion of Androgen Receptor Signaling From a Growth Suppressor in Normal Prostate Epithelial Cells to an Oncogene in Prostate Cancer Cells Involves a Gain of Function in c-Myc Regulation
Donald J. Vander Griend et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/-catenin/TCF-4 complex inhibition of c-MYC transcription
Lizamma Antony et al.
PROSTATE (2014)
Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer
Masis Isikbay et al.
HORMONES & CANCER (2014)
Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone
Mary Nakazawa et al.
HORMONES & CANCER (2014)
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
Yingming Li et al.
CANCER RESEARCH (2013)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
The PSA-/Io Prostate Cancer Cell Population Harbors Self-Renewing Long-Term Tumor-Propagating Cells that Resist Castration
Jichao Qin et al.
CELL STEM CELL (2012)
Activation of β-Catenin Signaling in Androgen Receptor-Negative Prostate Cancer Cells
Xinhai Wan et al.
CLINICAL CANCER RESEARCH (2012)
Cooperation between Polycomb and androgen receptor during oncogenic transformation
Jonathan C. Zhao et al.
GENOME RESEARCH (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
Changmeng Cai et al.
CANCER CELL (2011)
Increased CK5/CK8-Positive Intermediate Cells with Stromal Smooth Muscle Cell Atrophy in the Mice Lacking Prostate Epithelial Androgen Receptor
Yuanjie Niu et al.
PLOS ONE (2011)
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran et al.
CANCER DISCOVERY (2011)
Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails
Y. Niu et al.
ONCOGENE (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators
Shan Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling
Margaret M. Centenera et al.
MOLECULAR ENDOCRINOLOGY (2008)
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages
Yuanjie Niu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Androgen receptor is a tumor suppressor and proliferator in prostate cancer
Yuanjie Niu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex
Hannelore V. Heemers et al.
ENDOCRINE REVIEWS (2007)
Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor
Chun-Te Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function
Ulla Simanainen et al.
ENDOCRINOLOGY (2007)
Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer
Joanne N. Davis et al.
CANCER RESEARCH (2006)
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor
Ivan V. Litvinov et al.
PROSTATE (2006)
Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer
Zongxiang Zhou et al.
CANCER RESEARCH (2006)
Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
MA Titus et al.
CLINICAL CANCER RESEARCH (2005)
Mutation of the androgen receptor causes oncogenic transformation of the prostate
GZ Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program
RB Shah et al.
CANCER RESEARCH (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer
T Nishiyama et al.
CLINICAL CANCER RESEARCH (2004)
Formation of the androgen receptor transcription complex
YF Shang et al.
MOLECULAR CELL (2002)
Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium
M Stanbrough et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Progesterone receptor expression in human prostate cancer: Correlation with tumor progression
H Bonkhoff et al.
PROSTATE (2001)
分享论文
